P Stavem, T Gjemdal. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Administration, OralAdolescentAdultAgedBlood TransfusionCyclophosphamide/therapeutic useCytarabine/therapeutic useDaunorubicin/therapeutic useDrug Therapy, CombinationFemaleFollow-Up StudiesHumansInjections, IntravenousLeukemia/drug therapyLeukemia, Lymphoid/drug therapyLeukemia, Myeloid, Acute/drug therapyMaleMercaptopurine/therapeutic useMethotrexate/therapeutic useMiddle AgedPrednisone/therapeutic useRemission, SpontaneousThioguanine/therapeutic useTime FactorsVincristine/therapeutic use
Substances： See more » CytarabineVincristineCyclophosphamideMercaptopurineThioguaninePrednisoneMethotrexateDaunorubicin
Year: 1974 PMID： 4529548
Source DB: PubMed Journal: Acta Med Scand ISSN： 0001-6101